An elevated troponin result does not tell the whole clinical story. In this 2013 discussion, Rick Body explores high-sensitivity assays, chronic elevations and type 2 myocardial infarction, explaining why serial results need to be interpreted alongside the patient's presentation.
How seriously should we take ST depression when the patient is now pain-free? This hypothetical cardiology case explores dynamic ECG changes, serial troponin results and clinical context, then reviews the 2012 evidence on when patients with NSTEMI should undergo coronary intervention.
This 2012 journal club compares prasugrel with clopidogrel in acute coronary syndromes managed without revascularisation. Beyond the treatment comparison, it examines composite outcomes, all-cause mortality and confidence intervals, showing why the choice of endpoint can complicate interpretation of a clinical trial.
How do you act on an ECG suggesting STEMI when the rest of the presentation does not fit? This hypothetical cardiology case from 2012 combines altered consciousness, abdominal findings and no chest pain to explore competing diagnoses, bleeding risk and the urgency of reperfusion.
Could the ADAPT protocol identify chest-pain patients suitable for earlier discharge? This 2012 appraisal examines its combination of risk scoring and serial troponin testing, then questions symptom timing, external validation, assay choice and how many patients might actually avoid further investigation.
Who with chest pain needs investigation for acute coronary syndrome? Rick Body's 2012 discussion examines what symptoms and signs can—and cannot—tell us, challenges reliance on labels such as 'atypical', and explores the tension between avoiding missed diagnoses and reducing unnecessary admissions.
Practical perspectives on trauma care and team leadership.
Explore the series →